NB-203

N/A

Report date: 2024/07/16 11:55:01

Base Information

Drug NameNB-203
Drug Alias NameNB-203
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 1 inhibitorsVascular endothelial growth factor inhibitors
TargetsCarcinoembryonic antigen related cell adhesion molecule 1Vascular endothelial growth factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNeoLogics Bioscience Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeoLogics Bioscience Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A